Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
Barclays analyst Glen Santangelo maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $10 to $11.
Stocks · News reference
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
Raymond James Downgrades Phreesia to Market Perform
DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13